{"id":"https://openalex.org/W2582582167","doi":"https://doi.org/10.1017/cjn.2017.4","title":"Epigenetic landscape in IDH1 mutant glioma","display_name":"Epigenetic landscape in IDH1 mutant glioma","publication_year":2017,"publication_date":"2017-01-30","ids":{"openalex":"https://openalex.org/W2582582167","doi":"https://doi.org/10.1017/cjn.2017.4","mag":"2582582167"},"language":"fr","primary_location":{"id":"doi:10.1017/cjn.2017.4","doi":"https://doi.org/10.1017/cjn.2017.4","is_oa":true,"landing_page_url":"https://doi.org/10.1017/cjn.2017.4","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/D7E56883303B32591E442B9FA398DD07/S031716711700004Xa.pdf/div-class-title-epigenetic-landscape-in-idh1-mutant-glioma-div.pdf","source":{"id":"https://openalex.org/S3196323","display_name":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","issn_l":"0317-1671","issn":["0317-1671","2057-0155"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/D7E56883303B32591E442B9FA398DD07/S031716711700004Xa.pdf/div-class-title-epigenetic-landscape-in-idh1-mutant-glioma-div.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066684300","display_name":"Luolan Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Luolan Li","raw_affiliation_strings":["Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021775552","display_name":"Sitanshu Gakkhar","orcid":"https://orcid.org/0000-0002-2895-9921","observed_orcids":["https://orcid.org/0000-0002-2895-9921"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I4210133112","display_name":"Canada's Michael Smith Genome Sciences Centre","ror":"https://ror.org/0333j0897","country_code":"CA","type":"other","lineage":["https://openalex.org/I4210133112"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sitanshu Gakkhar","raw_affiliation_strings":["BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada","institution_ids":["https://openalex.org/I1289530486","https://openalex.org/I4210133112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059957688","display_name":"Misha Bilenky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I4210133112","display_name":"Canada's Michael Smith Genome Sciences Centre","ror":"https://ror.org/0333j0897","country_code":"CA","type":"other","lineage":["https://openalex.org/I4210133112"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Misha Bilenky","raw_affiliation_strings":["BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada","institution_ids":["https://openalex.org/I1289530486","https://openalex.org/I4210133112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056978004","display_name":"Anna\u00efck Carles","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Annaick Carles","raw_affiliation_strings":["Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042682747","display_name":"Alireza Heravi\u2010Moussavi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I4210133112","display_name":"Canada's Michael Smith Genome Sciences Centre","ror":"https://ror.org/0333j0897","country_code":"CA","type":"other","lineage":["https://openalex.org/I4210133112"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Alireza Heravi-Moussavi","raw_affiliation_strings":["BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada","institution_ids":["https://openalex.org/I1289530486","https://openalex.org/I4210133112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013441798","display_name":"Stephanie H. Cho","orcid":"https://orcid.org/0000-0001-5388-8849","observed_orcids":["https://orcid.org/0000-0001-5388-8849"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I4210133112","display_name":"Canada's Michael Smith Genome Sciences Centre","ror":"https://ror.org/0333j0897","country_code":"CA","type":"other","lineage":["https://openalex.org/I4210133112"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Stephanie Cho","raw_affiliation_strings":["BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada","institution_ids":["https://openalex.org/I1289530486","https://openalex.org/I4210133112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062678818","display_name":"Baljit Kamoh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I4210133112","display_name":"Canada's Michael Smith Genome Sciences Centre","ror":"https://ror.org/0333j0897","country_code":"CA","type":"other","lineage":["https://openalex.org/I4210133112"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Baljit Kamoh","raw_affiliation_strings":["BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada","institution_ids":["https://openalex.org/I1289530486","https://openalex.org/I4210133112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069285700","display_name":"Angela Tam","orcid":"https://orcid.org/0000-0001-6752-5707","observed_orcids":["https://orcid.org/0000-0001-6752-5707","https://orcid.org/0000-0003-0244-0109"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I4210133112","display_name":"Canada's Michael Smith Genome Sciences Centre","ror":"https://ror.org/0333j0897","country_code":"CA","type":"other","lineage":["https://openalex.org/I4210133112"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Angela Tam","raw_affiliation_strings":["BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada","institution_ids":["https://openalex.org/I1289530486","https://openalex.org/I4210133112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103016993","display_name":"Richard A. Moore","orcid":"https://orcid.org/0000-0002-3572-0572","observed_orcids":["https://orcid.org/0000-0002-3572-0572"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I4210133112","display_name":"Canada's Michael Smith Genome Sciences Centre","ror":"https://ror.org/0333j0897","country_code":"CA","type":"other","lineage":["https://openalex.org/I4210133112"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Richard Moore","raw_affiliation_strings":["BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada","institution_ids":["https://openalex.org/I1289530486","https://openalex.org/I4210133112"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andy Mungall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I4210133112","display_name":"Canada's Michael Smith Genome Sciences Centre","ror":"https://ror.org/0333j0897","country_code":"CA","type":"other","lineage":["https://openalex.org/I4210133112"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Andy Mungall","raw_affiliation_strings":["BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada","institution_ids":["https://openalex.org/I1289530486","https://openalex.org/I4210133112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100728059","display_name":"Steven J.M. Jones","orcid":"https://orcid.org/0000-0003-3394-2208","observed_orcids":["https://orcid.org/0000-0003-3394-2208","https://orcid.org/0000-0002-3927-3562"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I4210133112","display_name":"Canada's Michael Smith Genome Sciences Centre","ror":"https://ror.org/0333j0897","country_code":"CA","type":"other","lineage":["https://openalex.org/I4210133112"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Steven Jones","raw_affiliation_strings":["BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada","institution_ids":["https://openalex.org/I1289530486","https://openalex.org/I4210133112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070061359","display_name":"Marco A. Marra","orcid":"https://orcid.org/0000-0001-7146-7175","observed_orcids":["https://orcid.org/0000-0001-7146-7175"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I4210133112","display_name":"Canada's Michael Smith Genome Sciences Centre","ror":"https://ror.org/0333j0897","country_code":"CA","type":"other","lineage":["https://openalex.org/I4210133112"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Marco Marra","raw_affiliation_strings":["BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada","institution_ids":["https://openalex.org/I1289530486","https://openalex.org/I4210133112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044366354","display_name":"Stephen S. F. Yip","orcid":"https://orcid.org/0000-0002-8514-9861","observed_orcids":["https://orcid.org/0000-0002-8514-9861"]},"institutions":[{"id":"https://openalex.org/I2802832906","display_name":"Vancouver General Hospital","ror":"https://ror.org/02zg69r60","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I141074466","https://openalex.org/I2799475292","https://openalex.org/I2802832906"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Stephen Yip","raw_affiliation_strings":["Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, V5Z 1M9, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, V5Z 1M9, Canada","institution_ids":["https://openalex.org/I2802832906"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072313250","display_name":"Martin Hirst","orcid":"https://orcid.org/0000-0001-9136-9054","observed_orcids":["https://orcid.org/0000-0001-9136-9054"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]},{"id":"https://openalex.org/I4210133112","display_name":"Canada's Michael Smith Genome Sciences Centre","ror":"https://ror.org/0333j0897","country_code":"CA","type":"other","lineage":["https://openalex.org/I4210133112"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Martin Hirst","raw_affiliation_strings":["BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada","Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BC Cancer Agency Canada\u2019s Michael Smith Genome Science Center, Vancouver, BC, V5Z 4S6, Canada","institution_ids":["https://openalex.org/I1289530486","https://openalex.org/I4210133112"]},{"raw_affiliation_string":"Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada","institution_ids":["https://openalex.org/I141945490"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3550,"currency":"USD","value_usd":3550},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"44","issue":"S1","first_page":"S2","last_page":"S2"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oligodendroglioma","display_name":"oligodendroglioma","score":0.9779999852180481},{"id":"https://openalex.org/keywords/idh1-mutation","display_name":"IDH1 mutation","score":0.9509999752044678},{"id":"https://openalex.org/keywords/1p-19q-codeletion","display_name":"1p/19q codeletion","score":0.9139999747276306},{"id":"https://openalex.org/keywords/cic","display_name":"CIC","score":0.6919999718666077},{"id":"https://openalex.org/keywords/epigenetic-regulation","display_name":"epigenetic regulation","score":0.7860000133514404},{"id":"https://openalex.org/keywords/transcriptional-repression","display_name":"transcriptional repression","score":0.6970000267028809},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.7440000176429749},{"id":"https://openalex.org/keywords/spinocerebellar-ataxia","display_name":"spinocerebellar ataxia","score":0.9279999732971191},{"id":"https://openalex.org/keywords/low-grade-glioma","display_name":"low-grade glioma","score":0.7250000238418579},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.6899999976158142}],"concepts":[{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.7414547204971313},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.6604450941085815},{"id":"https://openalex.org/C127848430","wikidata":"https://www.wikidata.org/wiki/Q18027543","display_name":"IDH1","level":4,"score":0.6566072702407837},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.537168025970459},{"id":"https://openalex.org/C2778152352","wikidata":"https://www.wikidata.org/wiki/Q5165061","display_name":"Content (measure theory)","level":2,"score":0.5119079351425171},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.277041494846344},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.24569088220596313},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.159042090177536},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13412031531333923},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.05572307109832764},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1017/cjn.2017.4","doi":"https://doi.org/10.1017/cjn.2017.4","is_oa":true,"landing_page_url":"https://doi.org/10.1017/cjn.2017.4","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/D7E56883303B32591E442B9FA398DD07/S031716711700004Xa.pdf/div-class-title-epigenetic-landscape-in-idh1-mutant-glioma-div.pdf","source":{"id":"https://openalex.org/S3196323","display_name":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","issn_l":"0317-1671","issn":["0317-1671","2057-0155"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1017/cjn.2017.4","doi":"https://doi.org/10.1017/cjn.2017.4","is_oa":true,"landing_page_url":"https://doi.org/10.1017/cjn.2017.4","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/D7E56883303B32591E442B9FA398DD07/S031716711700004Xa.pdf/div-class-title-epigenetic-landscape-in-idh1-mutant-glioma-div.pdf","source":{"id":"https://openalex.org/S3196323","display_name":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","issn_l":"0317-1671","issn":["0317-1671","2057-0155"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2582582167.pdf","grobid_xml":"https://content.openalex.org/works/W2582582167.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2582102413","https://openalex.org/W2580702759","https://openalex.org/W2580330910","https://openalex.org/W2767313442","https://openalex.org/W2620561374","https://openalex.org/W2337352520","https://openalex.org/W2626084843","https://openalex.org/W2021630037","https://openalex.org/W1821314699","https://openalex.org/W1580723244"],"abstract_inverted_index":{"Oligodendroglioma":[0],"(ODG)":[1],"is":[2],"a":[3,31,37,61,93,101],"subtype":[4],"of":[5,50,57,70,82,85,96,104,118,159],"low":[6],"grade":[7],"glioma":[8],"marked":[9],"by":[10],"unique":[11,80,153],"clinical":[12,157],"and":[13,22,100,108,124,142,147],"genomic":[14],"characteristics":[15],"including":[16],"slow":[17],"predictable":[18],"progression,":[19],"IDH":[20,51],"mutation,":[21],"1p19qcodeletion.ODGs":[23],"are":[24,111],"more":[25],"sensitive":[26],"to":[27,30,48,91,132,152],"treatment":[28],"leading":[29],"favorable":[32],"prognosis.Recently,":[33],"mutations":[34,59],"in":[35,46,60,115,126,169],"CIC,":[36],"gene":[38],"found":[39,45],"on":[40,155],"chromosome":[41],"19q,":[42],"have":[43,87],"been":[44],"up":[47],"70%":[49],"mutated,":[52],"1p19q-codeleted":[53],"ODGs.The":[54],"high":[55],"frequency":[56],"CIC":[58,72,86,146],"hemizygous":[62],"state":[63],"indicates":[64],"that":[65],"loss":[66],"or":[67],"altered":[68],"function":[69],"the":[71,79,105,116,139,156],"protein":[73,90],"may":[74,150],"be":[75,92,133],"crucially":[76],"associated":[77],"with":[78],"biology":[81,129],"ODG.Previous":[83],"studies":[84],"shown":[88],"this":[89,135,170],"transcriptional":[94],"repressor":[95],"ETS":[97],"transcription":[98],"factors":[99],"negative":[102],"regulator":[103],"MAPK":[106],"pathway.CIC":[107],"ataxin-1-like":[109],"(ATXN1L)":[110],"also":[112],"closely":[113],"involved":[114],"pathology":[117],"spinocerebellar":[119],"ataxia":[120],"(SCA).However,":[121],"their":[122],"relationship":[123,144],"role":[125],"brain":[127,172],"tumour":[128],"has":[130],"yet":[131],"elucidated.In":[134],"study,":[136],"we":[137],"explore":[138],"molecular,":[140],"proteomic,":[141],"functional":[143],"between":[145],"ATXN1L":[148],"which":[149],"lead":[151],"insights":[154],"behavior":[158],"ODG":[160],"as":[161,163],"well":[162],"identify":[164],"potential":[165],"molecular":[166],"therapeutic":[167],"targets":[168],"enigmatic":[171],"tumour.":[173]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-02-03T00:00:00"}